Skip to main content

Find Clinical Trials

Home
Conditions
COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality

Clinical trial condition

COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality

Explore clinical trials studying COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality trial results

Completed

The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients

NCT05419206

Conditions: COVID-19, COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality, Coronaviridae Infections, +10 more
Locations: Hisar Hospital Intercontinental Istanbul, Turkey (Türkiye)

View Trial Details